Eleni Aretouli1, Konstantinos K Tsilidis2, Jason Brandt1. 1. Departments of Psychiatry and Behavioral Sciences and Neurology, Johns Hopkins University School of Medicine. 2. Department of Hygiene and Epidemiology, University of Ioannina School of Medicine.
Abstract
OBJECTIVE: The contribution of executive cognition (EC) to the prediction of incident dementia remains unclear. This prospective study examined the predictive value of EC for subsequent cognitive decline in persons with mild cognitive impairment (MCI) over a 4-year period. METHOD: One hundred forty-one persons with MCI (amnestic and nonamnestic, single- and multiple-domain) received a baseline and two biennial follow-up assessments. Eighteen tests, assessing six different aspects of EC, were administered at baseline and at 2-year follow-up, together with screening cognitive and daily functioning measures. Longitudinal logistic regression models and generalized estimating equations (GEE) were used to examine whether EC could predict progression to a Clinical Dementia Rating Scale (CDR; C. P. Hughes, L. Berg, W. L. Danziger, L. A. Coben, & R. L. Martin, 1982, A new clinical scale for the staging of dementia, British Journal of Psychiatry, Vol. 140, pp. 566-572) score of 1 or more over the 4-year period, first at the univariate level and then in the context of demographic and clinical characteristics, daily functioning measures, and other neurocognitive factors. RESULTS: Over the 4-year period, 56% of MCI patients remained stable, 35% progressed to CDR ≥ 1, and 8% reverted to normal (CDR = 0). Amnestic MCI subtypes were not associated with higher rates of progression to dementia, whereas subtypes with multiple impairments were so associated. Eight out of the 18 EC measures, including all three measures assessing inhibition of prepotent responses, predicted MCI outcome at the univariate level. However, the multivariate GEE model indicated that age, daily functioning, and overall cognitive functioning best predicted progression to dementia. CONCLUSION: Measures of EC (i.e., inhibitory control) are associated with MCI outcome. However, age and global measures of cognitive and functional impairment are better predictors of incident dementia.
OBJECTIVE: The contribution of executive cognition (EC) to the prediction of incident dementia remains unclear. This prospective study examined the predictive value of EC for subsequent cognitive decline in persons with mild cognitive impairment (MCI) over a 4-year period. METHOD: One hundred forty-one persons with MCI (amnestic and nonamnestic, single- and multiple-domain) received a baseline and two biennial follow-up assessments. Eighteen tests, assessing six different aspects of EC, were administered at baseline and at 2-year follow-up, together with screening cognitive and daily functioning measures. Longitudinal logistic regression models and generalized estimating equations (GEE) were used to examine whether EC could predict progression to a Clinical Dementia Rating Scale (CDR; C. P. Hughes, L. Berg, W. L. Danziger, L. A. Coben, & R. L. Martin, 1982, A new clinical scale for the staging of dementia, British Journal of Psychiatry, Vol. 140, pp. 566-572) score of 1 or more over the 4-year period, first at the univariate level and then in the context of demographic and clinical characteristics, daily functioning measures, and other neurocognitive factors. RESULTS: Over the 4-year period, 56% of MCI patients remained stable, 35% progressed to CDR ≥ 1, and 8% reverted to normal (CDR = 0). Amnestic MCI subtypes were not associated with higher rates of progression to dementia, whereas subtypes with multiple impairments were so associated. Eight out of the 18 EC measures, including all three measures assessing inhibition of prepotent responses, predicted MCI outcome at the univariate level. However, the multivariate GEE model indicated that age, daily functioning, and overall cognitive functioning best predicted progression to dementia. CONCLUSION: Measures of EC (i.e., inhibitory control) are associated with MCI outcome. However, age and global measures of cognitive and functional impairment are better predictors of incident dementia.
Authors: Douglas Galasko; David A Bennett; Mary Sano; Daniel Marson; Jeff Kaye; Steven D Edland Journal: Alzheimer Dis Assoc Disord Date: 2006 Oct-Dec Impact factor: 2.703
Authors: Donald R Royall; Edward C Lauterbach; Daniel Kaufer; Paul Malloy; Kerry L Coburn; Kevin J Black Journal: J Neuropsychiatry Clin Neurosci Date: 2007 Impact factor: 2.198
Authors: K Pérès; V Chrysostome; C Fabrigoule; J M Orgogozo; J F Dartigues; P Barberger-Gateau Journal: Neurology Date: 2006-08-08 Impact factor: 9.910
Authors: Steven H Ferris; Paul S Aisen; Jeffrey Cummings; Douglas Galasko; David P Salmon; Lon Schneider; Mary Sano; Peter J Whitehouse; Steven Edland; Leon J Thal Journal: Alzheimer Dis Assoc Disord Date: 2006 Oct-Dec Impact factor: 2.703
Authors: Mark W Bondi; Adam B Serody; Agnes S Chan; Sonja C Eberson-Shumate; Dean C Delis; Lawrence A Hansen; David P Salmon Journal: Neuropsychology Date: 2002-07 Impact factor: 3.295
Authors: Jeannie-Marie S Leoutsakos; Alexandra L Bartlett; Sarah N Forrester; Constantine G Lyketsos Journal: Alzheimers Dement Date: 2013-08-15 Impact factor: 21.566
Authors: Ryan Mulligan; Michael R Basso; Lily Lau; Bradley Reynolds; Douglas M Whiteside; Dennis Combs; Robert A Bornstein Journal: J Clin Exp Neuropsychol Date: 2019-01-14 Impact factor: 2.475
Authors: Chanmin Park; Won Sub Kang; Jong Woo Kim; Jong-Woo Paik; Young Jong Kim; Jun Hee Jeon; Mee Ae Lee; Jae Gwang Kim; Ji Young Song Journal: Psychiatry Investig Date: 2017-03-06 Impact factor: 2.505
Authors: Anders Wallin; Arto Nordlund; Michael Jonsson; Kaj Blennow; Henrik Zetterberg; Annika Öhrfelt; Jacob Stålhammar; Marie Eckerström; Mårten Carlsson; Erik Olsson; Mattias Göthlin; Johan Svensson; Sindre Rolstad; Carl Eckerström; Maria Bjerke Journal: J Cereb Blood Flow Metab Date: 2016-01 Impact factor: 6.200